Global Advisory Committee on Vaccine Safety, June 2012.
D000277:Adjuvants, Pharmaceutic / Q000009:adverse effects; D000535:Aluminum / Q000009:adverse effects; D005260:Female; D014943:Global Health; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D007774:Lactation; D011247:Pregnancy; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects; D012449:Safety; D013849:Thimerosal / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects; D014612:Vaccines / Q000009:adverse effects* / Q000627:therapeutic use*; D014944:World Health Organization
D000277:Adjuvants, Pharmaceutic; D007252:Influenza Vaccines; D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal; D000535:Aluminum